Kawasaki syndrome

Reviews of Infectious Diseases

Volumn 10, Issue 1, 1988, Pages 1-15

  Rowley, Anne H ^a,b   Gonzalez Crussi, Frank ^a   Shulman, Stanford T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DISEASE; HUMAN; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOLOGY; PRESCHOOL CHILD; REVIEW;

CHILD, PRESCHOOL; CORONARY DISEASE; HUMAN; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; SUPPORT, NON-U.S. GOV'T;

EID: 0023744719     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/10.1.1     Document Type: Article

References (89)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [Japanese]. Japanese Journal of Allergy 1967;16:178-222
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6
3. Melish ME, Hicks RM, Larson EJ. Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 1976;130:599-607
4. Morens DM, Anderson LJ, Hurwitz ES. National surveillance of Kawasaki disease. Pediatrics 1980;65:21-5
5. Shulman ST, ed. Kawasaki disease: Proceedings of the Second International Kawasaki Disease Symposium. New York, NY: Alan R. Liss, 1987
6. Centers for Disease Control. Kawasaki disease-New York. MMWR 1980;29:61-3
7. Slovis TL, Hight DW, Philippart AI, Dubois RS. Sonography in the diagnosis and management of hydrops of the gallbladder in children with mucocutaneous lymph node syndrome. Pediatrics 1980;65:789-94
8. Asai T. Evaluation method for the degree of seriousness in Kawasaki disease. Acta Pediatrica Japonica (overseas edition) 1983;25:170-5
9. Bell DM, Morens DM, Holman RC, Hurwitz ES, Hunter MK. Kawasaki syndrome in the United States 1976 to 1980. Am J Dis Child 1983;137:211-4
10. Vargo TA, Huhta JC, Moore WH, Person DA, Edwards MS. Recurrent Kawasaki disease. Pediatr Cardiol 1986;6:199-202
11. Fujiwara H, Fujiwara T, Kao T-C, Ohshio G, Hamashima Y. Pathology of Kawasaki disease in the healed stage. Acta Pathol Jpn 1986;36:857-67
12. Salo E, Pelkonen P, Pettay O. Outbreak of Kawasaki syn-drome in Finland. Acta Paediatr Scand 1986;75:75-80
13. Canter CE, Bower RJ, Strauss AW. Atypical Kawasaki disease with aortic aneurysm. Pediatrics 1981;68:885-8
14. Burns JC, Wiggins JW Jr, Toews WH, Newburger JW, Leung DYM, Wilson H, Glode MP. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 1986;109:759-63
15. Rowley AH, Gonzalez-Crussi F, Gidding SS, Duffy CE, Shul-man ST. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 1987;110:409-13
16. Kusakawa S and Heiner DC. Elevated levels of immunoglob-ulin E in the acute febrile mucocutaneous lymph node syndrome. Pediatr Res 1976;10:108-11
17. Burns JC, Glode MP, Clarke SH, Wiggins J, Hathaway WE. Coagulopathy and platelet activation in Kawasaki syndrome: Identification of patients at high risk for development of coronary artery aneurysms. J Pediatr 1984;105: 206-11
18. Fossard C, Thompson RA. Mucocutaneous lymph-node syn-drome (Kawasaki disease): Probable soluble-complex disorder. Br Med J 1977;1:883-4
19. Corbeel L, Delmotte B, Standaert L, Casteels-Van Daele M, Eeckels R. Kawasaki disease in Europe [letter]. Lancet 1977;1:797
20. Mason WH, Jordan SC, Sakai R, Takahashi M, Bernstein B. Circulating immune complexes in Kawasaki syndrome. Pediatr Infect Dis 1985;4:48-51
21. Levin M, Holland PC, Nokes TJC, Novelli V, Mola M, Levinsky RJ, Dillon MJ, Barratt TM, Marshall WC. Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. Br Med J 1985;290:1456-60
22. Miyata K, Kawakami K, Onimaru T, Baba Y, Ono S, Hokono-hara M, Yoshinaga M, Terawaki T. Circulating immune complexes and granulocytes chemotaxis in Kawasaki disease. Jpn Cire J 1984;48:1350-3
23. Ono S, Onimaru T, Kawakami K, Hokonohara M, Miyata K. Impaired granulocyte chemotaxis and increased circulating immune complexes in Kawasaki disease. J Pediatr 1985;106:567-70
24. Leung DYM, Siegel RL, Grady S, Krensky A, Meade R, Rein-herz EL, Geha RS. Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Im-munopathol 1982;23:100-12
25. Leung DYM, Chu ET, Wood N, Grady S, Meade R, Geha RS. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol 1983;130:2002-4
26. Barron KS, Lewis DE, DeCunto C, Blifeld C. Immune ab-normalities in children with Kawasaki syndrome [abstract]. Conference on Rheumatic Diseases of Childhood. Park City, Utah: 1986
27. Laxer R, Silverman E, Myones B, Schaffer F, Yount W, Duffy C, Fuller C, Gelfand E, Stein L. Lymphocyte abnormalities and complement activation in Kawasaki disease [abstract]. Conference on Rheumatic Diseases of Childhood. Park City, Utah: 1986
28. Bell DM, Brink EW, Nitzkin JL, Hall CB, Wulff H, Ber-kowitz ID, Feorino PM, Holman RC, Huntley CL, Meade RH III, Anderson LJ, Cheeseman SH, Fiumara NJ, Gil-fillan RF, Keim DE, Modlin JF. Kawasaki syndrome: Description of two outbreaks in the United States. New Engl J Med 1981;304:1568-75
29. Yanagawa H, Shigematsu I, Kusakawa S, Kawasaki T. Epidemiology of Kawasaki disease in Japan. Acta Paedi-atra Japonica 1979;21(1):1-10
30. Yanagawa H. Results of nationwide surveys on Kawasaki dis-ease. In: Shigematsu I, Yanagawa H, Kawasaki T, eds. Kawasaki disease epidemiological data book. Tokyo: Soft Science-sha Publications, 1986:37-51
31. Yanagawa H and Shigematsu I. Epidemiological features of Kawasaki disease in Japan. Acta Paediatr Japonica (overseas edition) 1983;25:94-107
32. Dean AG, Melish ME, Hicks R, Palumbo NE. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr 1982;100:552-7
33. Centers for Disease Control. Multiple outbreaks of Kawasaki syndrome-United States. MMWR 1985;34:33-5
34. Kato S, Kimura M, Tsuji K, Kusakawa S, Asai T, Juji T, Kawasaki T. HLA antigens in Kawasaki disease. Pediatrics 1978;61:252-5
35. Matsuda I, Hattori S, Nagata N, Fruse A, Nambu H, Itakura K, Wakisaka A. HLA antigens in mucocutaneous lymph node syndrome. Am J Dis Child 1977;131:1417-8
36. Melish M. Kawasaki syndrome. Pediatr Ann 1982;11:255-68
37. Shulman ST, McAuley JB, Pachman LM, Miller ML, Rusch-haupt DG. Epidemiology of Kawasaki syndrome in an urban U.S. area with a small Asian population. Am J Dis Child 1987;141:420-5
38. Hamashima Y, Kishi K, Tasaka K. Rickettsia-like bodies in infantile acute febrile mucocutaneous lymph-node syndrome [letter]. Lancet 1973;2:42
39. Kato H, Fujimoto T, Inoue O, Kondo M, Koga Y, Yamamoto S, Shingu M, Tominaga K, Sasaguri Y. Variant strain of Propionibacterum acnes: A clue to the etiology of Kawasaki disease. Lancet 1983;2:1383-7
40. Furusho K, Ohba T, Soeda T, Kimoto K, Okabe T, Hirota T. Possible role for mite antigen in Kawasaki disease [letter]. Lancet 1981;2:194-5
41. Patriarca PA, Rogers MF, Morens DM, Schönberger LB, Kaminski RM, Burns JC, Glode MP. Kawasaki syndrome: Association with the application of rug shampoo. Lancet 1982;2:578-80
42. Lin F-YC, Bailowitz A, Koslowe P, Israel E, Kaslow RA. Kawasaki syndrome: A case-control study during an outbreak in Maryland. Am J Dis Child 1985;139:277-9
43. Klein BS, Rogers MF, Patrican LA, White MC, Burgdorfer W, Schell WL, Kochel RL, Marchette NJ, McPherson JT, Nelson DB, Yolken RH, Wortmann D, Davis JP. Kawasaki syndrome: A controlled study of an outbreak in Wisconsin. Am J Epidemiol 1986;124:306-16
44. Centers for Disease Control. Kawasaki Syndrome-Massa-chusetts. MMWR 1980;29:369-71
45. Rauch AM, Hurwitz ES, Schönberger LB, Nihill M, Kaplan SL, Seavy DE, Reeve GR. Cluster of Kawasaki syndrome cases, Harris County, Texas. In: Program and abstracts of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 1985
46. Shulman ST and Rowley AH. Does Kawasaki disease have a retroviral aetiology? Lancet 1986;2:545-6
47. Burns JC, Geha RS, Schneeberger EE, Newburger JW, Rosen FS, Glezen LS, Huang AS, Natale J, Leung DYM. Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature 1986;323:814-6
48. Joshi VV, Connor E, Oleske JM, Mendelson J, Sharer L, Keresztes J, Marin J. Cardiovascular involvement in fatal cases of pediatric acquired immunodeficiency syndrome. In: Program and abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 1986
49. The MCLS Research Committee Report 6th Nationwide sur-vey in Japan. Shonika 1981;22:53-8
50. Kato H. Data presented at the First International Kawasaki Symposium. Hawaii: January 1984
51. Hirose O, Misawa H, Kijima Y, Yamada O, Arakaki Y, Kajino Y, Ryujin Y, Kowata T, Echigo S, Kamiya T. Two-dimensional echocardiography of coronary artery in Kawasaki disease (MCLS): Detection, changes in acute phase, and follow-up observation of the aneurysm [Japanese; English abstract]. J Cardiogr 1981;11:89-104
52. Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, Rikitake N. Fate of coronary aneurysms in Kawasaki disease: Serial coronary angiography and long-term follow-up study. Am J Cardiol 1982;49:1758-66
53. Tomita Y, Baba K, Fukaya T, Yamakawa M. Coronary ar-terial responses to intracoronary nitroglycerin in Kawasaki disease [abstract]. In: Proceedings of the Second World Congress of Pediatric Cardiology. New York: Springer Verlag, 1985
54. Yoshikawa J, Yanagihara K, Owaki T, Kato H, Takagi Y, Okumachi F, Fukaya T, Tomita Y, Baba K. Cross-sectional echocardiographic diagnosis of coronary artery aneurysms in patients with the mucocutaneous lymph node syndrome. Circulation 1979;59:133-9
55. Nakano H, Saito A, Ueda K, Nojima K. Clinical characteristics of myocardial infarction following Kawasaki disease: Report of 11 cases. J Pediatr 1986;108:198-203
56. Flugelman MY, Hasin Y, Bassan MM, Leor R, Gotsman MS. Acute myocardial infarction 14 years after an acute episode of Kawasaki’s disease. Am J Cardiol 1983;52:427-8
57. Pounder DJ. Coronary artery aneurysms presenting as sudden death 14 years after Kawasaki disease in infancy. Arch Pathol Lab Med 1985;109:874-6
58. Kohr RM. Progressive asymptomatic coronary artery disease as a late fatal sequela of Kawasaki disease. J Pediatr 1986;108:256-9
59. Gorgels APM, Braat SHGJ, Becker AE, Raab THJM, Boeh-mer AG, Da Costa AJ, Van Der Poel AJM, Wellens HJJ. Multiple aneurysms of the coronary arteries as the cause of sudden death in childhood. Am J Cardiol 1986;57:1193-4
60. Oliveira DBG, Foale RA, Bensaid J. Coronary artery aneurysms and Kawasaki’s disease in an adult. Br Heart J 1984;51:91-3
61. Trillo AA, Scharyj M, Prichard RW. Coronary artery aneurysm and myocardial infarction resulting in sudden death of a 6-year-old child. Am J Forensic Med Pathol 1980;1: 349-54
62. Takao A, Kusakawa S, Hamada I, Ando M, Asai T. Cardio-vascular lesions of mucocutaneous lymph node syndrome. Circulation 1974;50:111-39
63. Kitamura S, Kawashima Y, Kawachi K, Harima R, Ihara K, Nakano S, Shimazaki Y, Mori T. Severe mitral regurgitation due to coronary arteritis of mucocutaneous lymph node syndrome. J Thorac Cardiovasc Surg 1980;80:629-36
64. Nakano H, Nojima K, Saito A, Ueda K. High incidence of aortic regurgitation following Kawasaki disease. J Pediatr 1985;107:59-63
65. Imakita M, Sasaki Y, Misugi K, Miyazawa Y, Hyodo Y. Kawasaki disease complicated with mitral insufficiency. Autopsy findings with special reference to valvular lesion. Acta Pathol Jpn 1984;34:605-16
66. Gidding SS, Shulman ST, Ilbawi M, Crussi F, Duffy CE. Mucocutaneous lymph node syndrome (Kawasaki disease): Delayed aortic and mitral insufficiency secondary to active valvulitis. J Am Coll Cardiol 1986;7:894-7
67. Fukushige J, Nihill MR, McNamara DG. Spectrum of car-diovascular lesions in mucocutaneous lymph node syndrome: Analysis of eight cases. Am J Cardiol 1980;45:98-107
68. Landing BH, Larson EJ. Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics 1977;59:651-62
69. Tanaka N, Sekimoto K and Naoe S. Kawasaki disease: Relationship with infantile periarteritis nodosa. Arch Pathol Lab Med 1976;100:81-6
70. Tanaka N, Sekimoto K, Fukushima T, Tbkita H, Ueno T, Naoe S. Pathological study of fatal MCLS cases of Kawasaki disease: Relationship with infantile polyarteritis nodosa. In: Proceedings of the International Workshop on Vascular Lesions of Collagen Diseases and Related Conditions. Tokyo: Japan Medical Research Foundation, 1976:44
71. Fauci AS, moderator, NIH conference: The spectrum of vas-culitis. Clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978;89:660-76
72. Amano S, Hazama F and Hamashima Y. Pathology of Kawasaki disease. II. Distribution and incidence of the vascular lesions. Jpn Circ J 1979;43:741-8
73. Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease. I. Pathology and morphogenesis of the vascular changes. Jpn Circ J 1979;43:633-43
74. Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: A pathological study. J Pediatr 1982;100:225-31
75. Fujiwara H and Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978;61:100-7
76. Carter RF, Haynes ME and Morton J. Rickettsia-like bodies and splenitis in Kawasaki disease [letter]. Lancet 1976; 1:1254-5
77. Giesker DW, Krause PJ, Pastuszak WT, Hine P, Forouhar FA. Lymph node biopsy for early diagnosis in Kawasaki disease. Am J Surg Pathol 1982;6:493-501
78. Kegel SM, Dorsey TJ, Rowen M, Taylor WF. Cardiac death in mucocutaneous lymph node syndrome. Am J Cardiol 1977;40:282-6
79. Marsh WL Jr, Bishop JW and Koenig HM. Bone marrow and lymph node findings in a fatal case of Kawasaki’s disease. Arch Pathol Lab Med 1980;104:563-7
80. Koren G, Rose V, Lavi S, Rowe R. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease. JAMA 1985;254:767-9
81. Kato H, Koike S, Yokoyama T. Kawasaki disease: Effect of treatment on coronary artery involvement. Pediatrics 1979;63:175-9
82. Harada K, Tatara K, Asai T, Sonobe T, Yanagawa H, Kusakawa S, Kawasaki T. Prospective controlled study for the treatment of Kawasaki disease [abstract]. In: Proceedings of the Second World Congress of Pediatric Cardiology. New York: Springer Verlag, 1985
83. Furusho K, Kamiya T, Nakano H, Kiyosama N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, Kawarano M, Baba K, Baba K, Mori C. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2:1055-8
84. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP, Shulman ST, Wiggins JW, Hicks RV, Fulton DR, Lewis AB, Leung DYM, Colton T, Rosen FS, Melish ME. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7
85. Terai M, Ogata M, Sugimoto K, Nagai Y, Toba T, Tamai K, Aotsuka H, Niwa K, Nakajima H. Coronary arterial thrombi in Kawasaki disease. J Pediatr 1985;106:76-8
86. Kitamura S, Kawachi K, Harima R, Sakakibara T, Hirose H, Kawashima Y. Surgery for coronary heart disease due to mucocutaneous lymph node syndrome (Kawasaki disease): Report of 6 patients. Am J Cardiol 1983;51:444-8
87. Sandiford FM, Vargo TA, Shih J-Y, Pelargonio S, McNamara DG. Successful triple coronary artery bypass in a child with multiple coronary aneurysms due to Kawasaki’s disease. J Thorac Cardiovasc Surg 1980;79:283-7
88. Hirose H, Kawashima Y, Nakano S, Matsuda H, Sakakibara T, Hiranaka T, Imagawa H, Ogawa M, Harima R. Long-term results in surgical treatment of children 4 years old or younger with coronary involvement due to Kawasaki disease. Circulation 1986;74(Suppl I): I-77-81
89. Kitamura S. Surgery for coronary heart disease due to mucocutaneous lymph node syndrome (Kawasaki disease). In: Shulman ST, ed. Kawasaki disease: Proceedings of the Second International Kawasaki Disease Symposium. New York, NY: Alan R. Liss, 1987